Clinically, PCa is commonly treated by AR pathway perturbation, such as androgen suppression via surgical or chemical castration [gonadotropin-releasing hormone (GnRH) analogs] means (Palmbos and Hussain, 2013). The gene discussed is AR; the disease is posterior cortical atrophy.